Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Type 1 diabetes is an autoimmune disease characterized by T-cell-mediated destruction of pancreatic beta cells.
• Loss of immunological tolerance to self-antigens is a hallmark of type 1 diabetes.
• Regulatory T-cells (Tregs) play a crucial role in maintaining peripheral tolerance.

Purpose of the Study:

• To investigate the function and phenotype of CD4(+)CD25(+) Tregs in patients with recent-onset adult type 1 diabetes.
• To determine if a deficiency in Treg function contributes to the loss of self-tolerance in type 1 diabetes.
• To explore potential alterations in Treg markers associated with type 1 diabetes.

Main Methods:

• Analysis of CD4(+)CD25(+) T-cell levels in type 1 diabetes patients and controls.
• In vitro coculture assays to assess Treg suppressive function.
• Measurement of cytokine profiles (interferon-gamma, interleukin-10) in cocultures.
• Flow cytometry to evaluate coexpression of activation markers (CD69) and intracellular CTLA-4 on Tregs.

Main Results:

• CD4(+)CD25(+) T-cell numbers were normal in type 1 diabetes patients.
• Tregs from type 1 diabetes patients exhibited significantly reduced ability to suppress T-cell proliferation.
• Cocultures from type 1 diabetes patients showed a proinflammatory cytokine profile (increased interferon-gamma, decreased interleukin-10).
• A higher proportion of Tregs in type 1 diabetes patients coexpressed CD69 and intracellular CTLA-4.

Conclusions:

• Patients with type 1 diabetes have functionally impaired CD4(+)CD25(+) Tregs.
• This Treg dysfunction may contribute to the breakdown of self-tolerance and pathogenesis of type 1 diabetes.
• Altered Treg phenotype, indicated by CD69 and CTLA-4 expression, may be associated with impaired function.